Updated:
Ferro Holdings
Kevin Ferro established Ferro Holdings LLC in 2019 after exiting Vatera Holdings, the alternative-investment advisor he led as CEO and CIO from 2006 to 2018.
Ferro Holdings
Kevin Ferro established Ferro Holdings LLC in 2019 after exiting Vatera Holdings, the alternative-investment advisor he led as CEO and CIO from 2006 to 2018. Ferro had earlier founded Ferro Capital with offices in New York and Frankfurt and held senior roles at Commerzbank and the D. E. Shaw Group in New York, London, and Tokyo. The firm operates as a single-family office and holding company that oversees both liquid and illiquid assets for the Ferro family. The portfolio spans equities, fixed income, commodities, real estate, hedge funds, and private equity, with explicit emphasis on direct healthcare investments and life-sciences opportunities. Investment stages include early-stage and middle-market transactions executed via direct co-investments, SPVs, and fund-of-funds commitments. Confirmed geographic reach covers North America, Europe, and Asia. Past board roles include Pearl Therapeutics, sold to AstraZeneca for up to $1.2 billion, and Kos Pharmaceuticals, sold to Abbott Labs for $4.2 billion. No headcount or AUM figures appear in public materials. The firm maintains its headquarters at 219 Dixie Blvd in Delray Beach, Florida, and lists additional properties in Palm Beach, Sag Harbor, and Stowe, Vermont. Kevin Ferro serves on the Board of Trustees of Pine Crest School; he completed a term on the Prep for Prep board in 2025. Via Coquina, a related entity, belongs to 1% for the Planet. Ferro Holdings functions as both an investment vehicle and a family-owned holding company, allowing direct ownership of operating businesses alongside third-party manager allocations. This hybrid structure separates the family’s philanthropic vehicles, including Kevin and Cara Ferro Philanthropy, from the investment mandate while retaining board oversight of select portfolio companies.
General information
Firm type
Single Family Office
Year founded
2019
Location
Region
North America
Country
United States
City
Delray Beach
Corporate office
Delray Beach, FL, United States
Principals
Kevin Ferro
Founder and CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Ferro Holdings?
Kevin Ferro serves as Founder and CEO and sets the investment mandate. He previously acted as CEO and CIO of Vatera Holdings and Ferro Capital.
Does Ferro Holdings participate in fund commitments or only direct deals?
The firm uses both approaches. It allocates to third-party managers and executes direct co-investments and SPVs, particularly in healthcare.
What investment stages does Ferro Holdings typically target?
The office targets early-stage and middle-market opportunities, with documented activity in clinical-stage biotech and specialty pharmaceuticals.
Where does the underlying wealth come from?
The capital originates from Kevin Ferro’s career in alternative investments and from proceeds of prior business sales including Kos Pharmaceuticals and Pearl Therapeutics.
How is Ferro Holdings related to Vatera Healthcare Partners?
Kevin Ferro founded and led Vatera Holdings until its sale in 2018; Ferro Holdings is the subsequent family office vehicle that continues similar strategies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: